SA

Santosh Arun Singh

Active Director Director DIN 07699522
DIN 07699522 First appointment Mar 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2017
Shareholding value •••• Premium profile

About Santosh Arun Singh

Data last updated:

Santosh Arun Singh is a Director at Exsell Laboratories Private Limited (since 2017). The company operates in Pharma. Exsell Laboratories Private Limited reported revenue of ₹4.33 Cr (FY 2024).

DIN 07699522
Primary Designation Director
Industry Pharma
First Appointment 03 Mar 2017
Oldest Company Age 9 yrs
Largest company Exsell Laboratories Private Limited · ₹4.33 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Exsell Laboratories Private Limited U52520MH2017PTC291942
Director03 Mar 20172017₹4.33 Cr (FY 2024)Active

Board colleagues of Santosh Arun Singh

Directorship timeline

Open interactive timeline →
Exsell Laboratories Private Limited
Premium access

Shareholding and investment profile for Santosh Arun Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Santosh Arun Singh

Santosh Arun Singh currently holds 1 directorship: Exsell Laboratories Private Limited (Director, since 03 Mar 2017, revenue ₹4.33 Cr (FY 2024)).

Santosh Arun Singh was first appointed on 03 Mar 2017 as Director at Exsell Laboratories Private Limited.

The current boards of Santosh Arun Singh's companies include Arunkumar Mathuraprasad Singh (Exsell Laboratories Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available